Market Research Logo

Debiopharm International S.A. - Product Pipeline Review - 2015

Debiopharm International S.A. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Debiopharm International S.A. - Product Pipeline Review - 2015’, provides an overview of the Debiopharm International S.A.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Debiopharm International S.A.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Debiopharm International S.A. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Debiopharm International S.A.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Debiopharm International S.A.’s pipeline products
Reasons to buy
  • Evaluate Debiopharm International S.A.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Debiopharm International S.A. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Debiopharm International S.A.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Debiopharm International S.A. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Debiopharm International S.A.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Debiopharm International S.A. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Debiopharm International S.A. Snapshot
Debiopharm International S.A. Overview
Key Information
Key Facts
Debiopharm International S.A. - Research and Development Overview
Key Therapeutic Areas
Debiopharm International S.A. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Debiopharm International S.A. - Pipeline Products Glance
Debiopharm International S.A. - Late Stage Pipeline Products
Phase III Products/Combination Treatment Modalities
Debiopharm International S.A. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Debiopharm International S.A. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Debiopharm International S.A. - Drug Profiles
triptorelin pamoate PR
Product Description
Mechanism of Action
R&D Progress
alisporivir
Product Description
Mechanism of Action
R&D Progress
Debio-1450
Product Description
Mechanism of Action
R&D Progress
Debio-1452
Product Description
Mechanism of Action
R&D Progress
AT-406
Product Description
Mechanism of Action
R&D Progress
Debio-1347
Product Description
Mechanism of Action
R&D Progress
Debio-0617B
Product Description
Mechanism of Action
R&D Progress
Debio-0719
Product Description
Mechanism of Action
R&D Progress
Debio-0929
Product Description
Mechanism of Action
R&D Progress
Debio-0930B
Product Description
Mechanism of Action
R&D Progress
Debio-0826
Product Description
Mechanism of Action
R&D Progress
Debio-1348
Product Description
Mechanism of Action
R&D Progress
Debio-1449
Product Description
Mechanism of Action
R&D Progress
Debio-1453
Product Description
Mechanism of Action
R&D Progress
Debio-1454
Product Description
Mechanism of Action
R&D Progress
Debiopharm International S.A. - Pipeline Analysis
Debiopharm International S.A. - Pipeline Products by Target
Debiopharm International S.A. - Pipeline Products by Route of Administration
Debiopharm International S.A. - Pipeline Products by Molecule Type
Debiopharm International S.A. - Pipeline Products by Mechanism of Action
Debiopharm International S.A. - Recent Pipeline Updates
Debiopharm International S.A. - Dormant Projects
Debiopharm International S.A. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
CUDC-305
Debiopharm International S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Debiopharm International S.A., Key Information
Debiopharm International S.A., Key Facts
Debiopharm International S.A. - Pipeline by Indication, 2015
Debiopharm International S.A. - Pipeline by Stage of Development, 2015
Debiopharm International S.A. - Monotherapy Products in Pipeline, 2015
Debiopharm International S.A. - Partnered Products in Pipeline, 2015
Debiopharm International S.A. - Partnered Products/ Combination Treatment Modalities, 2015
Debiopharm International S.A. - Phase III, 2015
Debiopharm International S.A. - Phase II, 2015
Debiopharm International S.A. - Phase I, 2015
Debiopharm International S.A. - Preclinical, 2015
Debiopharm International S.A. - Discovery, 2015
Debiopharm International S.A. - Pipeline by Target, 2015
Debiopharm International S.A. - Pipeline by Route of Administration, 2015
Debiopharm International S.A. - Pipeline by Molecule Type, 2015
Debiopharm International S.A. - Pipeline Products by Mechanism of Action, 2015
Debiopharm International S.A. - Recent Pipeline Updates, 2015
Debiopharm International S.A. - Dormant Developmental Projects,2015
Debiopharm International S.A. - Discontinued Pipeline Products, 2015
Debiopharm International S.A., Subsidiaries
List of Figures
Debiopharm International S.A. - Pipeline by Top 10 Indication, 2015
Debiopharm International S.A. - Pipeline by Stage of Development, 2015
Debiopharm International S.A. - Monotherapy Products in Pipeline, 2015
Debiopharm International S.A. - Partnered Products in Pipeline, 2015
Debiopharm International S.A. - Pipeline by Top 10 Target, 2015
Debiopharm International S.A. - Pipeline by Top 10 Route of Administration, 2015
Debiopharm International S.A. - Pipeline by Top 10 Molecule Type, 2015
Debiopharm International S.A. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report